MedCity Update – March 2017
To view this email in a web browser, go here
Sarah Haywood

Welcome – Sarah Haywood, CEO, MedCity

I write this having just returned from a whistle-stop visit to Berlin, where I have been supporting the Mayor’s campaign to encourage collaboration between London and Europe in light of Article 50 being triggered this week. Of course, as always, I was there to represent the whole of the Golden Triangle of London, Oxford and Cambridge. It was a pleasure to chair a panel around innovation with key players from Germany and I had chance to meet some exciting companies on the Mayor’s International Business Programme, including Diabetology – based in London, but working with both Oxford and Cambridge – Medical Realities and StepJockey.  

This month, we also announced the winners of our £2m Collaborate to Innovate programme. I’m excited for this diverse range of SME-academic partnerships to get started and we’ll keep you updated on their progress. Read below to find out about the winners.

This week we also worked with Liftstream, a life sciences executive recruiter, to host an event looking at solutions to the lack of diversity on BioPharma boardrooms. Over 150 people attended to see industry leaders share their honest experiences and how they think we can tackle this important issue. MedCity board member Annalisa Jenkins chaired one of the panels and we have been well supported by members of our Advisory Board in this work. We will be sharing a report soon but, in the meantime, do let me know what actions you think could be taken to improve diversity on life sciences boards over on Twitter @MedCityHQ

Collaborate to Innovate winners announced

Collaborate to Innovate winners announced!

We have selected 16 projects for our £2m Collaborate to Innovate programme; encouraging SME/academic partnerships and commercialisation within the region. King’s College London, Imperial College London, University College London and Queen Mary University of London (pictured) are providing their time and expertise to start-up companies to enable them to take that next step.

Read more

StepJockey expands into Germany

One of the first companies to raise funds through our Angels in MedCity programme has announced a new German distribution partnership on the #LondonIsOpen European visit.

Read more

StepJockey expands into Germany
Neuroscience Forum

350 neuroscience experts come to London

The first World Neuroscience Innovation Forum outside of Boston was at The Crick on Monday, with speakers from Alzheimer’s UK, Harvard Medical School and AstraZeneca leading the bill.

Read a brief overview

£14m investment for London Cancer Hub

An important step forward for the London Cancer Hub as Sutton Council purchases land for the £1bn development.The ambition is for this to be a global centre for cancer innovation.

Read more

£14m London Cancer Hub investment
Capital Cell set for UK launch

Capital Cell set for UK launch

Specialist equity crowdfunding platform, Capital Cell, recently helped Spanish biotech Bionure raise over €1m. They will launch their UK platform in April at the next Angels in MedCity pitching event at The Crick.

Find out more

LiveSmart gets AiMC funding

LiveSmart is 16th company to get AiMC funding!

LiveSmart, a preventive digital health solution, is the latest company to gain private investment through Angels in MedCity. This new funding will support them to resource trial studies and continue to build its technology.

Find out about LiveSmart

Sarah hosts life sciences panel

MedCity leads life sciences arm of #LondonIsOpen visit

Sarah joined London’s Deputy Mayor for Business, Rajesh Agrawal, and representatives from Siemens, Bayer, Pfizer and others at WeWork Sony Center Berlin on Monday to boost tech and life sciences trade links.

Read more about the campaign 

MedCity was established in April 2014 by the Mayor of London with the Higher Education Funding Council for England and the capital’s three Academic Health Science Centres – Imperial College Academic Health Centre, King’s Health Partners and UCL Partners.

The next edition of MedCity Update will be sent in April 2017.

©2017 MedCity. All rights reserved.